- Home
- Publications
- Publication Search
- Publication Details
Title
Biologic therapies and bone loss in rheumatoid arthritis
Authors
Keywords
Antirheumatic agents, Bone fractures, Monoclonal antibodies, Osteoporosis, Rheumatic diseases
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 28, Issue 2, Pages 429-446
Publisher
Springer Nature
Online
2016-10-31
DOI
10.1007/s00198-016-3769-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
- (2016) Emilio Martin-Mola et al. RHEUMATOLOGY INTERNATIONAL
- Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss
- (2015) Akilan Krishnamurthy et al. ANNALS OF THE RHEUMATIC DISEASES
- Evolutionary medicine and bone loss in chronic inflammatory diseases—A theory of inflammation-related osteopenia
- (2015) Rainer H. Straub et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab
- (2015) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- Anti-citrullinated peptides as autoantigens in rheumatoid arthritis—relevance to treatment
- (2014) Lazaros I. Sakkas et al. AUTOIMMUNITY REVIEWS
- Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
- (2014) Glenn Haugeberg et al. BMC MUSCULOSKELETAL DISORDERS
- IL-6 Alters Osteocyte Signaling toward Osteoblasts but Not Osteoclasts
- (2014) A.D. Bakker et al. JOURNAL OF DENTAL RESEARCH
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cell Costimulation Molecules CD80/86 Inhibit Osteoclast Differentiation by Inducing the IDO/Tryptophan Pathway
- (2014) A. Bozec et al. Science Translational Medicine
- Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
- (2013) Joel Kremer et al. ANNALS OF INTERNAL MEDICINE
- Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
- (2013) Arnd Kleyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity
- (2013) Roland Kocijan et al. ANNALS OF THE RHEUMATIC DISEASES
- Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis
- (2013) Maurizio Cutolo et al. AUTOIMMUNITY REVIEWS
- Temporal differential effects of proinflammatory cytokines on osteoclastogenesis
- (2013) SU-JIN MOON et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study
- (2012) Stephanie Finzel et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis
- (2012) Linda Dirven et al. BMC MUSCULOSKELETAL DISORDERS
- Tofacitinib for the treatment of rheumatoid arthritis
- (2012) Cristiano AF Zerbini et al. Expert Review of Clinical Immunology
- Increased frequency of osteoporosis and BMD below the expected range for age among South Korean women with rheumatoid arthritis
- (2012) Seung-Geun Lee et al. International Journal of Rheumatic Diseases
- Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss
- (2012) Melda Onal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
- (2012) Ulrike Harre et al. JOURNAL OF CLINICAL INVESTIGATION
- Association between osteoporosis and psoriasis: results from the Longitudinal Health Insurance Database in Taiwan
- (2012) J. J. Keller et al. OSTEOPOROSIS INTERNATIONAL
- Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study
- (2012) C. L. M. Krieckaert et al. RHEUMATOLOGY
- Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage
- (2012) Mona Helmy Abdel Meguid et al. RHEUMATOLOGY INTERNATIONAL
- IL-6 Receptor Inhibition Positively Modulates Bone Balance in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-Tumor Necrosis Factor Therapy: Biochemical Marker Analysis of Bone Metabolism in the Tocilizumab RADIATE Study (NCT00106522)
- (2012) Morten A. Karsdal et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Influence of Infliximab on Cytokines Network and Markers of Bone Remodeling in Rheumatoid Arthritis Patients
- (2012) Izabela Korczowska et al. YONSEI MEDICAL JOURNAL
- Initiation of Tumor Necrosis Factor α Antagonists and Risk of Fractures in Patients With Selected Rheumatic and Autoimmune Diseases
- (2012) Vivian K. Kawai et al. ARTHRITIS CARE & RESEARCH
- Inflammatory Rheumatic Disorders and Bone
- (2012) Irene E. M. Bultink et al. Current Rheumatology Reports
- Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis
- (2011) Maria J H Boumans et al. ANNALS OF THE RHEUMATIC DISEASES
- Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
- (2011) L. Yeo et al. ANNALS OF THE RHEUMATIC DISEASES
- Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway
- (2011) Melissa M. Matzelle et al. ARTHRITIS AND RHEUMATISM
- Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
- (2011) Mari Hoff et al. BMC MUSCULOSKELETAL DISORDERS
- Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression
- (2011) Wing-Yee Cheung et al. BONE
- Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population-based cohort study
- (2011) Seo Young Kim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Circulating Dickkopf-1 Is Correlated with Bone Erosion and Inflammation in Rheumatoid Arthritis
- (2011) SHI-YAO WANG et al. JOURNAL OF RHEUMATOLOGY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts
- (2011) Jason M. Hodge et al. PLoS One
- Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
- (2011) Katsuaki Kanbe et al. RHEUMATOLOGY INTERNATIONAL
- Osteoimmunology and osteoporosis
- (2011) Piet Geusens et al. ARTHRITIS RESEARCH & THERAPY
- Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss
- (2010) Brahmchetna Bedi et al. Annals of the New York Academy of Sciences
- Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis
- (2010) D. A. Eekman et al. ANNALS OF THE RHEUMATIC DISEASES
- Treating rheumatoid arthritis to target: recommendations of an international task force
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
- (2010) G. R. Heiland et al. ANNALS OF THE RHEUMATIC DISEASES
- Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high resolution computed tomography
- (2010) Christian M. Stach et al. ARTHRITIS AND RHEUMATISM
- The amazing osteocyte
- (2010) Lynda F Bonewald JOURNAL OF BONE AND MINERAL RESEARCH
- Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
- (2010) Jun Hashimoto et al. Modern Rheumatology
- Do RANKL inhibitors (denosumab) affect inflammation and immunity?
- (2010) S. Ferrari-Lacraz et al. OSTEOPOROSIS INTERNATIONAL
- High disease activity is a predictor of cortical hand bone loss in post-menopausal patients with established rheumatoid arthritis: a 5-year multicentre longitudinal study
- (2010) M. Hoff et al. RHEUMATOLOGY
- Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment
- (2010) A. El Maghraoui et al. RHEUMATOLOGY
- Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
- (2010) Gert Hein et al. RHEUMATOLOGY INTERNATIONAL
- The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis
- (2010) Peter Oelzner et al. RHEUMATOLOGY INTERNATIONAL
- Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis
- (2010) John T. Sharp et al. ARTHRITIS CARE & RESEARCH
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients
- (2010) A. Deodhar et al. ARTHRITIS CARE & RESEARCH
- Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis
- (2010) Seo Young Kim et al. ARTHRITIS RESEARCH & THERAPY
- Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
- (2010) Melek Güler-Yüksel et al. ARTHRITIS RESEARCH & THERAPY
- Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study
- (2009) S W Syversen et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-1 is essential for systemic inflammatory bone loss
- (2009) K Polzer et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
- (2009) R. K. Dore et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
- (2009) Roland Axmann et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor α and interleukin-1β modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes
- (2009) A. D. Bakker et al. ARTHRITIS AND RHEUMATISM
- Rapid and sustained improvement in bone and cartilage turnover markers with the antiâinterleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone
- (2009) Patrick Garnero et al. ARTHRITIS AND RHEUMATISM
- Animal models of rheumatoid arthritis
- (2009) Darren L. Asquith et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Factors Influencing Fracture Risk, T Score, and Management of Osteoporosis in Patients With Rheumatoid Arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) Registry
- (2009) Kathryn A. Coulson et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-α antibody: A novel mechanism of osteoclastogenesis by IL-17
- (2009) Toru Yago et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Osteoimmunology and the effects of the immune system on bone
- (2009) Hiroshi Takayanagi Nature Reviews Rheumatology
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- CTLA-4 directly inhibits osteoclast formation
- (2008) R Axmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss
- (2008) C A Wijbrandts et al. ANNALS OF THE RHEUMATIC DISEASES
- Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies
- (2008) J. K. de Vries-Bouwstra et al. ARTHRITIS AND RHEUMATISM
- Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis
- (2008) Kageyama Yasunori et al. CLINICAL RHEUMATOLOGY
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
- (2008) Willscott E. Naugler et al. TRENDS IN MOLECULAR MEDICINE
- Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis
- (2007) M Guler-Yuksel et al. ANNALS OF THE RHEUMATIC DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started